Diabetes Clinical Trials in Baltimore

Showing 481-500 of 576 trials

Evaluating the Effects of a Diet and Exercise Program in People With Type 2 Diabetes or Prediabetes: (The SHAPE3 Study)

NCT00928005

Type 2 diabetes and prediabetes, which are mainly caused by a lack of physical activity and excess weight, put people at an increased risk of cardiovascular disease. This study will compare the effects of a weight loss diet versus a weight loss diet plus an exercise program on body composition and cardiovascular factors that are early predictors of future cardiovascular disease in overweight and obese people with type 2 diabetes and prediabetes.

OverweightObesityType 2 Diabetes+1 more

Johns Hopkins University77 participantsStarted Jul 2009

Baltimore, Maryland, United States

COMPLETEDNA< 1 mile

Problem Solving and Cardiovascular Disease Risk Management in Diabetic Blacks

NCT00201110

The purpose of this study is to test a measurement tool and a new training intervention for problem solving in self-management of high cardiovascular disease (CVD) risk in African Americans with type 2 diabetes.

Cardiovascular DiseasesHeart DiseasesDiabetes Mellitus, Type 2+1 more

Johns Hopkins University139 participantsStarted Jul 2004

Baltimore, Maryland, United States

COMPLETEDPhase 27.6 miles

A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)

NCT00901979

This study will assess the effect of LCQ when added to metformin.

Type 2 Diabetes Mellitus

Novartis Pharmaceuticals693 participantsStarted Apr 2009

Mesa, Arizona, United States • Mesa, Arizona, United States • Little Rock, Arkansas, United States +64 more locations

Evaluating the Effects of a Diet and Exercise Program in People With Type 2 Diabetes or Prediabetes: (The SHAPE3 Study)

Problem Solving and Cardiovascular Disease Risk Management in Diabetic Blacks

A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)

Diabetes Trials in Other Cities

The CANTATA-MSU Trial (CANagliflozin Treatment And Trial Analysis - Metformin and SUlphonylurea)

Multicenter Worksite Nutrition Study

Evaluation of Low Source of Signal in SCOUT DS

Interferon-Alpha for Diabetes Mellitus Type 1

Safety and Efficacy of Xenical in Children and Adolescents With Obesity-Related Diseases

Screening for Early Evidence of Diabetes

Impact of a Diabetes Risk Score on Lifestyle Education and Patient Adherence

Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus

Study of Safety and Efficacy of PF-04991532 in Subjects With Type 2 Diabetes

A Trial of TT223 in Patients With Type 2 Diabetes Who Are Taking Metformin and/or Thiazolidinedione

A 6 Week Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of GK1-399 in Type 2 Diabetes

Fasiglifam in Type 2 Diabetic Subjects With Chronic Kidney Disease Stage 4 or 5 on Hemodialysis

Diabetes and Periodontal Therapy Trial

Safety and Efficacy of Once-daily Oral Administrations of TZP-102 for Gastroparesis in Patients With Diabetes Mellitus

Effect Of Paricalcitol (Zemplar) On Endothelial Function And Inflammation In Type 2 Diabetes And Chronic Kidney Disease

Evaluate Efficacy, Safety and Tolerability of AZD1656 as Add-on Treatment to Metformin in Type 2 Diabetes Mellitus (TD2M) Patients

Insulins Glargine and gluLisine strAtegy Versus Premixed Insulin strAteGy: a cOmparative Study

Other Conditions in Baltimore